Evidence map›Paper›PMID 38362905›Full record

ArticleBJPsych open2024

Emotions and behaviours of child and adolescent psychiatric patients during the COVID-19 pandemic.

Claudine Laurent-Levinson, Anne-Sophie Pellen, Hugues Pellerin, Cyril Hanin, Juliette Bouzy, Marie Devernay, Vanessa Milhiet, Xavier Benarous, Angèle Consoli, Jianxin Shi and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJPsych open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Claudine Laurent-LevinsonDepartment of Child and Adolescent Psychiatry, Centre de Référence des Maladies Rares à Expression Psychiatrique, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, France; and Groupe de Recherche Clinique n 15 - Troubles Psychiatriques et Développement (PSYDEV), Faculty of Medicine, Sorbonne Université, Paris, France.ORCID https://orcid.org/0000-0001-6550-3635
Anne-Sophie PellenDepartment of Child and Adolescent Psychiatry, Centre de Référence des Maladies Rares à Expression Psychiatrique, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, France; and Groupe de Recherche Clinique n 15 - Troubles Psychiatriques et Développement (PSYDEV), Faculty of Medicine, Sorbonne Université, Paris, France.
Hugues PellerinDepartment of Child and Adolescent Psychiatry, Centre de Référence des Maladies Rares à Expression Psychiatrique, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, France; and Groupe de Recherche Clinique n 15 - Troubles Psychiatriques et Développement (PSYDEV), Faculty of Medicine, Sorbonne Université, Paris, France.
Cyril HaninDepartment of Child and Adolescent Psychiatry, Centre de Référence des Maladies Rares à Expression Psychiatrique, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, France; and Groupe de Recherche Clinique n 15 - Troubles Psychiatriques et Développement (PSYDEV), Faculty of Medicine, Sorbonne Université, Paris, France.
Juliette BouzyDepartment of Child and Adolescent Psychiatry, Centre de Référence des Maladies Rares à Expression Psychiatrique, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, France.
Marie DevernayUnité de Médecine pour Adolescents, Armand-Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, France.
Vanessa MilhietGroupe de Recherche Clinique n 15 - Troubles Psychiatriques et Développement (PSYDEV), Faculty of Medicine, Sorbonne Université, Paris, France; and Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, France.
Xavier BenarousGroupe de Recherche Clinique n 15 - Troubles Psychiatriques et Développement (PSYDEV), Faculté de Médecine Sorbonne Université, Paris, France; and Department of Child and Adolescent Psychopathology, Amiens University Hospital, Amiens, France.
Angèle ConsoliDepartment of Child and Adolescent Psychiatry, Centre de Référence des Maladies Rares à Expression Psychiatrique, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, France; and Groupe de Recherche Clinique n 15 - Troubles Psychiatriques et Développement (PSYDEV), Faculty of Medicine, Sorbonne Université, Paris, France.
Jianxin ShiBiostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Douglas F LevinsonGroupe de Recherche Clinique n 15 - Troubles Psychiatriques et Développement (PSYDEV), Faculty of Medicine, Sorbonne Université, Paris, France; and Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California, USA.ORCID https://orcid.org/0000-0001-8223-1301
David CohenDepartment of Child and Adolescent Psychiatry, Centre de Référence des Maladies Rares à Expression Psychiatrique, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, France; Groupe de Recherche Clinique n 15 - Troubles Psychiatriques et Développement (PSYDEV), Faculty of Medicine, Sorbonne Université, Paris, France; and CNRS UMR 7222, Institute for Intelligent Systems and Robotics, Sorbonne University, Paris, France.
Sorbonne Université · FRAssistance Publique – Hôpitaux de Paris · FRCentre National de la Recherche Scientifique · FRNational Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious pandemics have had negative effects on mental health, but there are few data on children and adolescents who were receiving ongoing psychiatric treatment.

aimsTo study changes in emotions and clinical state, and their predictors, during the COVID-19 pandemic in France.

methodWe administered (by interview) the baseline Youth Self-Report version of the CoRonavIruS Health Impact Survey v0.3 (CRISIS, French translation) to 123 adolescent patients and the Parent/Caregiver version to evaluate 99 child patients before and during the first 'lockdown'. For 139 of these patients who received ongoing treatment in our centre, treating physicians retrospectively completed longitudinal global ratings for five time periods, masked to CRISIS ratings.

resultsThe main outcome measure was the sum of eight mood state items, which formed a single factor in each age group. Overall, this score improved for each age group during the first lockdown. Clinician ratings modestly supported this result in patients without intellectual disability or autism spectrum disorder. Improvement of mood states was significantly associated with perceived improvement in family relationships in both age groups.

conclusionsConsistent with previous studies of clinical cohorts, our patients had diverse responses during the pandemic. Several factors may have contributed to the finding of improvement in some individuals during the first lockdown, including the degree of family support or conflict, stress reduction owing to isolation, limitations of the outcome measures and/or possible selection bias. Ongoing treatment may have had a protective effect. Clinically, during crises additional support may be needed by families who experience increased conflict or who care for children with intellectual disability.

Indexed as

Children and adolescentsCOVID-19pandemicpsychiatric disordersresilience

Identifiers

PMID38362905
PMCPMC10897707
OpenAlexW4391884094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.